Product Earth, Drumsheds, London (2026)

Dive into the heart of wellness and sustainability at Product Earth – the ultimate showcase of alternative therapies, natural products & medicines.

16/10/2026

Stigma thrives in the dark. It weakens when we challenge it.

The more we question the narrative, share knowledge and expose the contradictions, the harder it becomes to justify outdated perceptions.

The conversation is changing. So should the stigma.

Question the narrative. End the hypocrisy.

15/10/2026

The plant hasn’t changed.

The laws have. And yet, the stigma remains.

How can the same plant be a medicine, a crime and a commercial opportunity?

Question the narrative. End the hypocrisy.

14/10/2026

For 23 years, Bedrocan grew the medicinal cannabis the Dutch Government supplied to patients around the world.

When the law changed in the UK in 2018, Bedrocan oils were imported for children with epilepsy. Support from the NHS and MPs was thin, and despite promises of a UK supply chain and research studies, by 2026 only 3 children had NHS-funded prescriptions. Other families pay for Bedrocan oils privately through clinics.

However, that supply is now under threat.
In 2024, the Dutch government announced a new framework for medicinal cannabis. Bedrocan’s contract to supply the Dutch government ended on 1 January 2026, but the new laws needed to allow it to sell directly are not expected until 2028.

As the politicians and regulators failed to act in time, Bedrocan’s Dutch company has now been declared bankrupt. Bedrocan’s plant is the raw material for Bedrolite and Bedica, the oils UK families rely on to control severe, treatment-resistant epilepsy.

A licensed UK pharmaceutical company has signed with Bedrocan to make, test and dispense these oils here. It cannot start without Bedrocan plant material, and the remaining stock is stuck in the Netherlands.

For Ben, these oils are the difference between hundreds of seizures a day and a stable life. He is one of many. The reports that families fear supplies will run out before the new year.

On 13 October, paulfostermp wrote to the Prime Minister for Ben’s mum, Joanne Griffiths, and the endourpain families. He asks Ministers to talk directly to the Dutch Government, release the remaining stock and secure a lasting supply. Swipe to read the letter.

What you can do today:
1. Sign Joanne’s petition. Link in bio.
2. Share this post to your stories and tag Andy Burnham
3. Ask your MP to back the letter.

The petition closes on 21 October. At 10,000 signatures the Government must respond. At 100,000 Parliament considers it for debate. Every signature this week counts, for Ben and hundreds of other children.
paulfostermp Andy Burnham

https://petition.parliament.uk/petitions/764594

12/10/2026

When it comes to cannabis, it’s easy to assume that a higher dose will deliver stronger relief. But the science is more nuanced than that.

A 2024 review published in Pain Medicine examined 44 publications exploring the effects of cannabis and cannabinoid-based treatments on pain, anxiety and sleep disturbance.

The researchers identified evidence suggesting that dose can influence the effects — and that the relationship isn’t always straightforward. In some circumstances, increasing the dose may not lead to better results, and effects can vary depending on the person, the condition and the cannabinoid treatment being used.

But there’s an important caveat: the researchers also highlighted significant gaps in the available human evidence. We still need more well-designed studies to understand which doses work best, for whom, and under what circumstances.

The takeaway? Cannabis isn’t a case of more is better. Finding the right approach matters more than simply increasing the amount.

Better research. Better understanding. Better-informed decisions. 🔬

Research: Shustorovich A, et al. Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review. Pain Medicine, 2024.

🔗 https://pubmed.ncbi.nlm.nih.gov/38268491/

11/10/2026

That unmistakable cannabis aroma comes from a complex mix of volatile compounds.

Terpenes such as myrcene, limonene and pinene contribute to the plant’s distinctive scent. But research has also identified volatile sulphur compounds that play a major role in its characteristic skunky smell.

Now, Canadian company CannabCo is challenging the norm with Odourless OG — cannabis flower developed to substantially reduce the traditional cannabis odour, without added fragrances or odour-masking agents.

The question is simple: if cannabis could be consumed with significantly less smell, would it change your experience?

Would you welcome it, or is the aroma part of what makes cannabis, cannabis?

Source:
CannabCo Pharmaceutical Corp. — Odourless OG product information. Product claims and reduced-odour positioning.

Address

Drumsheds
London
N183HF

Website

http://www.productearth.co/

Alerts

Be the first to know and let us send you an email when Product Earth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Product Earth